CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist
  • 66.87
  • +0.63+0.95%
Post Market Nov 18 15:00 CST
5.30BMarket Cap19.17P/E (TTM)

Hangzhou Alltest Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
10.37%618.03M
2.23%396.5M
-15.34%199.92M
-77.73%754.7M
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
Operating revenue
10.37%618.03M
2.23%396.5M
-15.34%199.92M
-77.73%754.7M
-81.40%559.94M
-85.76%387.85M
-88.75%236.14M
80.88%3.39B
201.96%3.01B
328.52%2.72B
Total operating cost
-2.91%425.1M
-10.78%272.93M
-19.44%144.14M
-66.17%592.08M
-68.81%437.85M
-73.52%305.91M
-77.30%178.93M
73.28%1.75B
213.10%1.4B
347.60%1.16B
Operating cost
-6.25%273.43M
-13.86%178.39M
-10.73%99.7M
-71.53%386.54M
-73.04%291.66M
-77.73%207.1M
-83.44%111.69M
61.64%1.36B
232.59%1.08B
411.45%929.81M
Operating tax surcharges
28.96%4.77M
37.89%3.58M
28.80%2.05M
-74.71%7.04M
-81.79%3.7M
-81.94%2.6M
-4.97%1.59M
180.28%27.82M
66.65%20.33M
140.14%14.37M
Operating expense
-11.72%41.89M
-7.95%30.05M
-35.15%10.81M
-53.91%69.29M
-64.18%47.45M
-68.30%32.64M
-60.92%16.67M
202.12%150.34M
338.21%132.46M
465.45%102.98M
Administration expense
-5.81%45.64M
-12.56%30.14M
-25.74%13.49M
-14.70%66.59M
-25.79%48.45M
-11.59%34.46M
-10.72%18.17M
138.61%78.06M
154.18%65.29M
102.79%38.98M
Financial expense
71.87%-12.13M
50.00%-18.39M
4.59%-5.08M
17.47%-58.54M
22.50%-43.11M
-19.01%-36.77M
-344.00%-5.32M
-300.76%-70.93M
-393.75%-55.62M
-496.50%-30.9M
-Interest expense (Financial expense)
-68.65%366.18K
-68.71%260.84K
-70.04%132.56K
-33.28%1.45M
-35.03%1.17M
-32.15%833.66K
-41.46%442.38K
224.69%2.17M
--1.8M
--1.23M
-Interest Income (Financial expense)
39.44%-17.86M
19.82%-17.48M
36.50%-5.37M
16.95%-35.62M
9.24%-29.49M
-37.90%-21.8M
-104.40%-8.45M
-13.14%-42.89M
-75.79%-32.49M
-11.59%-15.81M
Research and development
-20.28%71.5M
-25.38%49.16M
-35.89%23.16M
-41.55%121.17M
-43.72%89.69M
-34.08%65.88M
-22.89%36.12M
117.16%207.3M
140.80%159.38M
162.69%99.94M
Credit Impairment Loss
1.21%-13.94M
-13.89%-12.26M
-45.58%-11.37M
-102.06%-11.23M
-103.75%-14.11M
-72.34%-10.77M
-85.30%-7.81M
17.91%-5.56M
-281.11%-6.93M
-110.04%-6.25M
Asset Impairment Loss
-793.52%-7.31M
-275.45%-8.39M
68.09%-5.44M
102.00%5.6M
101.48%1.05M
106.72%4.78M
76.00%-17.06M
-7,016.09%-280.06M
-4,577.25%-71.08M
-1,870.70%-71.08M
Other net revenue
Fair value change income
354.49%22.55M
797.97%12.66M
-64.70%3.36M
314.66%32.67M
-83.25%4.96M
-90.61%1.41M
--9.53M
-171.36%-15.22M
--29.63M
--15.01M
Invest income
82.70%11.59M
46.95%9.21M
-9.77%4.2M
-64.20%8.63M
-56.10%6.34M
-49.29%6.26M
61.98%4.66M
246.83%24.12M
114.33%14.45M
130.20%12.35M
Asset deal income
750.33%3.48M
724.52%3.34M
99.28%-6.08K
-178.63%-419.22K
-3,438.20%-535.17K
-489,844.80%-535.17K
-774,917.52%-846.55K
1,004.34%533.17K
-44.92%16.03K
-100.38%-109.23
Other revenue
88.04%17.49M
74.27%13.92M
38.25%796.95K
-56.82%13.71M
-64.22%9.3M
-56.58%7.99M
-85.47%576.47K
99.67%31.75M
372.85%26M
371.73%18.4M
Operating profit
75.66%226.78M
55.97%142.05M
2.32%47.33M
-84.82%211.58M
-91.92%129.1M
-94.07%91.08M
-96.28%46.25M
55.43%1.39B
185.14%1.6B
304.20%1.54B
Add:Non operating Income
1,186.68%179.81K
1,186.18%179.74K
11,774.39%100K
-80.76%24.08K
-98.54%13.97K
-95.06%13.97K
-99.47%842.15
114.87%125.17K
2,573.07%957.06K
314,461,866.67%283.02K
Less:Non operating expense
-74.25%3.64M
-77.72%3.08M
35.77%271.7K
13.29%14.17M
45.09%14.15M
48.33%13.83M
-96.34%200.11K
879.44%12.51M
688.68%9.75M
817.50%9.32M
Total profit
94.25%223.32M
80.10%139.15M
2.39%47.16M
-85.71%197.44M
-92.77%114.96M
-94.94%77.26M
-96.28%46.06M
54.26%1.38B
184.18%1.59B
302.90%1.53B
Less:Income tax cost
87.89%25.77M
142.62%15.61M
-56.06%2.51M
-91.25%17.16M
-94.01%13.72M
-97.14%6.44M
-96.95%5.72M
50.94%195.99M
197.07%228.93M
323.76%224.93M
Net profit
95.11%197.55M
74.42%123.53M
10.68%44.64M
-84.79%180.28M
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.82%1.19B
182.12%1.36B
299.51%1.3B
Net profit from continuing operation
95.11%197.55M
74.42%123.53M
10.68%44.64M
-84.79%180.28M
-92.56%101.25M
-94.56%70.83M
-96.16%40.34M
54.82%1.19B
182.12%1.36B
299.51%1.3B
Less:Minority Profit
105.87%18.76K
2.86%-344.83K
26.37%-144.58K
-154.94%-295.58K
-283.53%-319.37K
-506.30%-355K
-120.88%-196.37K
--538.05K
--174.02K
--87.37K
Net profit of parent company owners
94.48%197.53M
74.03%123.88M
10.50%44.79M
-84.76%180.58M
-92.53%101.57M
-94.54%71.18M
-96.14%40.53M
54.75%1.18B
182.09%1.36B
299.48%1.3B
Earning per share
Basic earning per share
94.53%2.49
73.33%1.56
9.80%0.56
-84.75%2.28
-92.54%1.28
-94.52%0.9
-97.38%0.51
-1.32%14.95
79.31%17.16
137.43%16.43
Diluted earning per share
94.53%2.49
73.33%1.56
9.80%0.56
-84.75%2.28
--1.28
--0.9
--0.51
--14.95
----
----
Other composite income
-138.06%-1.48M
-86.37%648.53K
153.93%151.35K
-91.58%2.37M
-86.50%3.88M
-66.90%4.76M
-410.05%-280.66K
21,705.78%28.12M
16,975.15%28.78M
24,772.44%14.38M
Other composite income of parent company owners
-138.09%-1.48M
-86.58%637.99K
142.57%144.61K
-91.60%2.36M
-86.52%3.88M
-66.93%4.75M
-464.00%-339.7K
21,710.09%28.13M
16,983.33%28.79M
24,772.44%14.38M
Other composite income of minority owners
-89.24%285.66
149.32%10.55K
-88.58%6.74K
180.83%4.5K
119.25%2.65K
--4.23K
2,205.68%59.05K
---5.56K
---13.79K
----
Total composite income
86.50%196.07M
64.30%124.18M
11.83%44.8M
-84.95%182.65M
-92.43%105.13M
-94.26%75.59M
-96.18%40.06M
58.47%1.21B
187.99%1.39B
303.85%1.32B
Total composite income of parent company owners
85.92%196.05M
63.98%124.52M
11.79%44.93M
-84.92%182.94M
-92.41%105.45M
-94.23%75.94M
-96.17%40.19M
58.40%1.21B
187.96%1.39B
303.82%1.32B
Total composite income of minority owners
106.01%19.04K
4.70%-334.28K
-0.37%-137.84K
-154.67%-291.09K
-297.67%-316.72K
-501.46%-350.77K
-49.74%-137.33K
--532.49K
--160.23K
--87.37K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 10.37%618.03M2.23%396.5M-15.34%199.92M-77.73%754.7M-81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B
Operating revenue 10.37%618.03M2.23%396.5M-15.34%199.92M-77.73%754.7M-81.40%559.94M-85.76%387.85M-88.75%236.14M80.88%3.39B201.96%3.01B328.52%2.72B
Total operating cost -2.91%425.1M-10.78%272.93M-19.44%144.14M-66.17%592.08M-68.81%437.85M-73.52%305.91M-77.30%178.93M73.28%1.75B213.10%1.4B347.60%1.16B
Operating cost -6.25%273.43M-13.86%178.39M-10.73%99.7M-71.53%386.54M-73.04%291.66M-77.73%207.1M-83.44%111.69M61.64%1.36B232.59%1.08B411.45%929.81M
Operating tax surcharges 28.96%4.77M37.89%3.58M28.80%2.05M-74.71%7.04M-81.79%3.7M-81.94%2.6M-4.97%1.59M180.28%27.82M66.65%20.33M140.14%14.37M
Operating expense -11.72%41.89M-7.95%30.05M-35.15%10.81M-53.91%69.29M-64.18%47.45M-68.30%32.64M-60.92%16.67M202.12%150.34M338.21%132.46M465.45%102.98M
Administration expense -5.81%45.64M-12.56%30.14M-25.74%13.49M-14.70%66.59M-25.79%48.45M-11.59%34.46M-10.72%18.17M138.61%78.06M154.18%65.29M102.79%38.98M
Financial expense 71.87%-12.13M50.00%-18.39M4.59%-5.08M17.47%-58.54M22.50%-43.11M-19.01%-36.77M-344.00%-5.32M-300.76%-70.93M-393.75%-55.62M-496.50%-30.9M
-Interest expense (Financial expense) -68.65%366.18K-68.71%260.84K-70.04%132.56K-33.28%1.45M-35.03%1.17M-32.15%833.66K-41.46%442.38K224.69%2.17M--1.8M--1.23M
-Interest Income (Financial expense) 39.44%-17.86M19.82%-17.48M36.50%-5.37M16.95%-35.62M9.24%-29.49M-37.90%-21.8M-104.40%-8.45M-13.14%-42.89M-75.79%-32.49M-11.59%-15.81M
Research and development -20.28%71.5M-25.38%49.16M-35.89%23.16M-41.55%121.17M-43.72%89.69M-34.08%65.88M-22.89%36.12M117.16%207.3M140.80%159.38M162.69%99.94M
Credit Impairment Loss 1.21%-13.94M-13.89%-12.26M-45.58%-11.37M-102.06%-11.23M-103.75%-14.11M-72.34%-10.77M-85.30%-7.81M17.91%-5.56M-281.11%-6.93M-110.04%-6.25M
Asset Impairment Loss -793.52%-7.31M-275.45%-8.39M68.09%-5.44M102.00%5.6M101.48%1.05M106.72%4.78M76.00%-17.06M-7,016.09%-280.06M-4,577.25%-71.08M-1,870.70%-71.08M
Other net revenue
Fair value change income 354.49%22.55M797.97%12.66M-64.70%3.36M314.66%32.67M-83.25%4.96M-90.61%1.41M--9.53M-171.36%-15.22M--29.63M--15.01M
Invest income 82.70%11.59M46.95%9.21M-9.77%4.2M-64.20%8.63M-56.10%6.34M-49.29%6.26M61.98%4.66M246.83%24.12M114.33%14.45M130.20%12.35M
Asset deal income 750.33%3.48M724.52%3.34M99.28%-6.08K-178.63%-419.22K-3,438.20%-535.17K-489,844.80%-535.17K-774,917.52%-846.55K1,004.34%533.17K-44.92%16.03K-100.38%-109.23
Other revenue 88.04%17.49M74.27%13.92M38.25%796.95K-56.82%13.71M-64.22%9.3M-56.58%7.99M-85.47%576.47K99.67%31.75M372.85%26M371.73%18.4M
Operating profit 75.66%226.78M55.97%142.05M2.32%47.33M-84.82%211.58M-91.92%129.1M-94.07%91.08M-96.28%46.25M55.43%1.39B185.14%1.6B304.20%1.54B
Add:Non operating Income 1,186.68%179.81K1,186.18%179.74K11,774.39%100K-80.76%24.08K-98.54%13.97K-95.06%13.97K-99.47%842.15114.87%125.17K2,573.07%957.06K314,461,866.67%283.02K
Less:Non operating expense -74.25%3.64M-77.72%3.08M35.77%271.7K13.29%14.17M45.09%14.15M48.33%13.83M-96.34%200.11K879.44%12.51M688.68%9.75M817.50%9.32M
Total profit 94.25%223.32M80.10%139.15M2.39%47.16M-85.71%197.44M-92.77%114.96M-94.94%77.26M-96.28%46.06M54.26%1.38B184.18%1.59B302.90%1.53B
Less:Income tax cost 87.89%25.77M142.62%15.61M-56.06%2.51M-91.25%17.16M-94.01%13.72M-97.14%6.44M-96.95%5.72M50.94%195.99M197.07%228.93M323.76%224.93M
Net profit 95.11%197.55M74.42%123.53M10.68%44.64M-84.79%180.28M-92.56%101.25M-94.56%70.83M-96.16%40.34M54.82%1.19B182.12%1.36B299.51%1.3B
Net profit from continuing operation 95.11%197.55M74.42%123.53M10.68%44.64M-84.79%180.28M-92.56%101.25M-94.56%70.83M-96.16%40.34M54.82%1.19B182.12%1.36B299.51%1.3B
Less:Minority Profit 105.87%18.76K2.86%-344.83K26.37%-144.58K-154.94%-295.58K-283.53%-319.37K-506.30%-355K-120.88%-196.37K--538.05K--174.02K--87.37K
Net profit of parent company owners 94.48%197.53M74.03%123.88M10.50%44.79M-84.76%180.58M-92.53%101.57M-94.54%71.18M-96.14%40.53M54.75%1.18B182.09%1.36B299.48%1.3B
Earning per share
Basic earning per share 94.53%2.4973.33%1.569.80%0.56-84.75%2.28-92.54%1.28-94.52%0.9-97.38%0.51-1.32%14.9579.31%17.16137.43%16.43
Diluted earning per share 94.53%2.4973.33%1.569.80%0.56-84.75%2.28--1.28--0.9--0.51--14.95--------
Other composite income -138.06%-1.48M-86.37%648.53K153.93%151.35K-91.58%2.37M-86.50%3.88M-66.90%4.76M-410.05%-280.66K21,705.78%28.12M16,975.15%28.78M24,772.44%14.38M
Other composite income of parent company owners -138.09%-1.48M-86.58%637.99K142.57%144.61K-91.60%2.36M-86.52%3.88M-66.93%4.75M-464.00%-339.7K21,710.09%28.13M16,983.33%28.79M24,772.44%14.38M
Other composite income of minority owners -89.24%285.66149.32%10.55K-88.58%6.74K180.83%4.5K119.25%2.65K--4.23K2,205.68%59.05K---5.56K---13.79K----
Total composite income 86.50%196.07M64.30%124.18M11.83%44.8M-84.95%182.65M-92.43%105.13M-94.26%75.59M-96.18%40.06M58.47%1.21B187.99%1.39B303.85%1.32B
Total composite income of parent company owners 85.92%196.05M63.98%124.52M11.79%44.93M-84.92%182.94M-92.41%105.45M-94.23%75.94M-96.17%40.19M58.40%1.21B187.96%1.39B303.82%1.32B
Total composite income of minority owners 106.01%19.04K4.70%-334.28K-0.37%-137.84K-154.67%-291.09K-297.67%-316.72K-501.46%-350.77K-49.74%-137.33K--532.49K--160.23K--87.37K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data